Subject(s)
Urinary Incontinence, Stress/surgery , Female , Humans , Methods , Recurrence , Skin Transplantation , Transplantation, AutologousSubject(s)
Ergot Alkaloids/therapeutic use , Lactation Disorders/drug therapy , Prolactin/antagonists & inhibitors , Adult , Amenorrhea/chemically induced , Bromine/therapeutic use , Chlorpromazine/pharmacology , Contraceptives, Oral/adverse effects , Female , Follicle Stimulating Hormone/blood , Gonadotropin-Releasing Hormone/pharmacology , Humans , Luteinizing Hormone/blood , Menstruation/drug effects , Pregnancy , Progesterone/blood , Prolactin/blood , Radioimmunoassay , Thyrotropin-Releasing Hormone/pharmacologySubject(s)
Climacteric , Ovary/physiology , Adult , Female , Gonadotropins/physiology , Humans , Menopause , Middle Aged , Time FactorsSubject(s)
Cervix Uteri/physiopathology , Infertility, Female/physiopathology , Cervix Mucus , Female , HumansSubject(s)
Insemination, Artificial , Adult , Body Temperature , Female , Freezing , Germany, West , Humans , Infertility, Male , Jurisprudence , Male , Methods , PregnancySubject(s)
Amenorrhea/drug therapy , Ergot Alkaloids/therapeutic use , Fertility/drug effects , Lactation Disorders/drug therapy , Ovulation/drug effects , Adult , Amenorrhea/complications , Bromine/pharmacology , Bromine/therapeutic use , Clomiphene/therapeutic use , Dihydroxyphenylalanine/therapeutic use , Ergot Alkaloids/pharmacology , Estrogens/urine , Female , Gonadotropins/urine , Humans , Infant, Newborn , Lactation Disorders/complications , Menstruation Disturbances/drug therapy , Pituitary Hormones/physiology , Pregnancy , Pregnanediol/urine , Prolactin/antagonists & inhibitors , Prolactin/physiology , SyndromeSubject(s)
Adenoma, Chromophobe/complications , Pituitary Neoplasms/complications , Pregnancy Complications , 17-Ketosteroids/urine , Adenoma, Chromophobe/diagnostic imaging , Adult , Amenorrhea/drug therapy , Clomiphene/therapeutic use , Estradiol/urine , Estriol/urine , Female , Gonadotropins/urine , Humans , Infertility, Female/drug therapy , Pituitary Neoplasms/diagnostic imaging , Pregnancy , Pregnancy in Diabetics , RadiographySubject(s)
Ergot Alkaloids/pharmacology , Lactation/drug effects , Diethylstilbestrol/pharmacology , Female , Humans , Placebos , Pregnancy , Time FactorsABSTRACT
A double-blind trial was performed in 60 women to establish the effectiveness of an ergot alkaloid, 2-Br-alpha-ergocryptine (ergocryptine; CB 154), in suppressing puerperal lactation and to compare it with stilboestrol and a placebo. At the doses selected ergocryptine and stilboestrol were equally effective.
Subject(s)
Ergot Alkaloids/pharmacology , Lactation/drug effects , Postpartum Period , Breast/drug effects , Clinical Trials as Topic , Diethylstilbestrol/administration & dosage , Diethylstilbestrol/pharmacology , Dosage Forms , Ergot Alkaloids/administration & dosage , Female , Follow-Up Studies , Humans , Placebos , PregnancyABSTRACT
Three patients suffering from non-puerperal galactorrhoea over periods ranging from two months to six years were treated with an ergot alkaloid, 2-Br-alpha-ergocryptine (CB 154). In all three cases the galactorrhoea was terminated. The apparent prolactin antagonism exhibited by this compound is discussed.
Subject(s)
Ergot Alkaloids/therapeutic use , Lactation Disorders/drug therapy , Adult , Ergot Alkaloids/adverse effects , Female , Humans , Lactation Disorders/etiology , Pituitary Neoplasms/complications , Pregnancy , Prolactin/antagonists & inhibitorsABSTRACT
PIP: Frequency of trichomoniasis was studied in 6336 women by wet smear and Papanicolaou smear. The overall rate was 15%: 6.3% during pregnancy, 21.7% in the reproductive age group, 28.7% in women taking oral contraceptives, 22.2% in the climacteric, and 20.8% in postmenopausal women. 118 of the patients were treated with Fasigyn, a new trichomonacide. The drug was well tolerated. Oral administration sufficed for successful treatment. Complete cure was attained in 80% of those treated, and a further 12% showed significant improvement.^ieng